The Barron’s story deemed Mr. White “an industry pacesetter in product development and growth,” highlighting key strategic acquisitions during his 15-year tenure and the transformative decision to separate Abbott’s proprietary research-based pharmaceuticals business, creating AbbVie.
According to the story, the CEOs selected each year are not chosen by a statistical formula, but rather the line-up “reflects the views of Barron's reporters and editors, taking into account the opinions of investors, analysts, and industry executives.”
For inclusion on the global list, Barron’s prefers candidates that have been CEO of a large organization for at least five years.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.